Michael P. Dube - 02 Jul 2025 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role: VP, Chief Accounting Officer
Signature: James Basta, attorney-in-fact
Issuer symbol: NTLA
Transactions as of: 02 Jul 2025
Net transactions value: -$24,905
Form type: 4
Filing time: 03 Jul 2025, 16:07:21 UTC
Previous filing: 04 Mar 2025
Next filing: 03 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dube Michael P	VP, Chief Accounting Officer	C/O INTELLIA THERAPEUTICS, INC., 40 ERIE STREET; SUITE 130, CAMBRIDGE	James Basta, attorney-in-fact	03 Jul 2025	0002019493

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NTLA	Common Stock	Sale	$24,905	-2,503	-4.2%	$9.95	57,137	02 Jul 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 1, 2025, and does not represent a volitional trade by the Reporting Person.